Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026)

Revolution Medicines (RVMD) recorded quarterly Interest Coverage Ratio of 36.5 in Q1 2026, up 23.27% quarter-over-quarter from 47.57 in Q4 2025.

Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026) Analysis & Trends

Revolution Medicines' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 36.5 for Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 36.5; the TTM figure through Mar 2026 stood at 38.89 (changed N/A YoY), while the FY2025 annual figure was 6420.89, changed N/A from the prior year.
Interest Coverage Ratio was 36.5 for Q1 2026 at Revolution Medicines, up from 47.57 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 27.59 in Q3 2025 to a low of 50.15 in Q1 2024.
Historically, Interest Coverage Ratio has averaged 40.45 across 3 years, with a median of 42.04 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Revolution Medicines	32.33 Bn	32.33 Bn	-	-36.50

Download Data